When mood and time align: nasal esketamine reduces lived time disturbances in treatment-resistant depression.
International journal of psychiatry in clinical practice July 10, 2025 Stefan Jerotić, Milica Nestorovic, Janko Nešić et al. 3 citations
These two cases highlight the utility of a focused, structured clinical phenomenological interview in measuring treatment effectiveness in subjective experience. Two male patients, aged 35 and 27, of Serbian ethnicity with treatment-resistant depression were treated with nasal esketamine, with clinical progress monitored using both the Montgomery-Åsberg Depression Rating Scale (MADRS) and the...